Atrial Fibrillation Symptoms and Pain Sensitization

Region Örebro County

Status: Completed

Conditions: Atrial Fibrillation

Treatments: Diagnostic Test: Quantitative sensory testing

Study type: Interventional

Funder types: Other

Identifiers

NCT04649437

274094

Details and patient eligibility

About

Atrial fibrillation (AF) is the most common sustained arrhythmia and the number of patients with AF is expected to increase substantially in the coming decades. One third of patients with AF report no AF-associated symptoms, but up to one fourth report severe symptoms such as chest pain. It is well recognized, but unclear why patients' experience of AF-related symptoms, including chest pain, varies so much. Patients with chronic pain show a high degree of central sensitization, i.e. facilitated pain responses to repeated painful stimulation and impaired conditioned pain modulation, compared with controls. It is possible that patients with symptomatic AF may have developed pronounced pain sensitization even in the absence of chest pain as a symptom. No previous study has investigated pain sensitization in patients with AF.

The primary objective is to assess differences in pain sensitization in patients with symptomatic AF compared with patients with asymptomatic AF. Secondary objectives are to study the association of age, sex, AF duration, comorbidities and health-related quality of life to pain sensitization. A total of 30 patients with permanent AF (15 symptomatic and 15 asymptomatic) will be recruited. Patients will complete an AF-specific symptom score and a generic health-related quality of life questionnaire, and physicians will assess AF-related symptoms. Quantitative sensory testing recordings will be collected by pressure algometry. Assessment of temporal summation of pressure pain and conditioning pain modulation will be used to investigate the involvement of pain sensitization.

This preliminary pilot study will be used to estimate sample size for a larger study in which both patients and control subjects will be recruited, to further investigate whether patients with symptomatic AF have increased pain sensitization compared with patients with asymptomatic AF and controls. The studies may have an impact on individualized management of patients with AF in the future.

Enrollment: 30 patients

Sex: All

Ages: 20 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Male or female subjects 20 to 75 years old
• Permanent AF
• Previously completed AF-6
• Written informed consent

Exclusion criteria

• Paroxysmal or persistent AF
• Previous pulmonary vein isolation
• Psychiatric or cognitive condition
• Pregnancy
• Previous/current drug or alcohol abuse
• Previous neurological or concomitant musculoskeletal condition
• Continuous analgesic medication

Trial design

Primary purpose: Health Services Research

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

30 participants in 2 patient groups

Symptomatic patients

Other group

Description:

Subjects with symptoms of atrial fibrillation i.e. AF-6 sum score 30 points or more.

Treatment:

Diagnostic Test: Quantitative sensory testing

Asymptomatic patients

Other group

Description:

Subjects with no symptoms of atrial fibrillation i.e. AF-6 sum score = 0.

Treatment:

Diagnostic Test: Quantitative sensory testing